Although 4T1 parental-cell-derived tumors responded to anti-PD-L1 IgG therapy, the statistical difference between the control and anti-PD-L1 IgG group was smaller than in clone-16-derived tumor-bearing mice (Figure 2a). Here, CD274 is linked to neoplasm.